Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ruud Lensen"'
Publikováno v:
International Medical Case Reports Journal
International Medical Case Reports Journal, 14, 573-576
International Medical Case Reports Journal, 14, pp. 573-576
International Medical Case Reports Journal, 14, 573-576
International Medical Case Reports Journal, 14, pp. 573-576
Purpose: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection impacted morbidity and mortality during the pandemic of 2020-2021. A number of anti-COVID-19 vaccines have been developed with an unprecedented speed. While these vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e524378a0137dbd4f4ac085d8a4c09
http://europepmc.org/articles/PMC8412816
http://europepmc.org/articles/PMC8412816
Publikováno v:
International Medical Case Reports Journal
Lensen R, Netea MG, Rosendaal FR. Int Med Case Rep J. 2021;14:573–576. Page 574, Results, third paragraph, Blood test on day 5, Leucocytes row, the text “109” should read “108”. The authors apologize for this error. Read the original articl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d31765db31223c20f374ee20fc047652
https://doi.org/10.2147/imcrj.s345551
https://doi.org/10.2147/imcrj.s345551
Publikováno v:
European journal of epidemiology, 21(6), 469-473. Springer Netherlands
The association between the presence of CCR5 Delta32 heterozygosity and incidence of clinical herpes zoster was studied among 296 homosexual men from the Amsterdam cohort study (ACS) infected with human immunodeficiency virus type I (HIV-1) with an e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::983a0e4a5d90dd1db0abf3ceffee8e38
https://doi.org/10.1007/s10654-006-9017-x
https://doi.org/10.1007/s10654-006-9017-x
Publikováno v:
Journal of Thrombosis and Haemostasis. 1:1771-1776
Summary. Elevated factor (F)VIII levels contribute to venous thrombotic risk. FVIII levels are determined to a large extent by levels of von Willebrand factor (VWF), its carrier protein which protects FVIII against proteolysis. VWF levels are largely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b587f3327ee78de4d7637936db7fdb4e
https://doi.org/10.1046/j.1538-7836.2003.00314.x
https://doi.org/10.1046/j.1538-7836.2003.00314.x
Publikováno v:
British Journal of Haematology. 114:380-386
Summary. Factor V Leiden (FVL)-carrying relatives of selected patients with venous thromboembolism (VTE) have much higher venous thrombotic risks than FVLcarrying relatives of unselected consecutive patients with VTE. To find an explanation for this,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d325c7447872359ec4e9f00d1dc6d2c
https://doi.org/10.1046/j.1365-2141.2001.02946.x
https://doi.org/10.1046/j.1365-2141.2001.02946.x
Publikováno v:
British Journal of Haematology. 110:939-945
Factor V Leiden (FVL) leads to a sevenfold increased risk of venous thrombosis and is present in 50% of individuals from families referred because of unexplained familial thrombophilia. We assessed the association of FVL with venous thromboembolism (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a72acc4458b1a651800c64826e59ff31
https://doi.org/10.1046/j.1365-2141.2000.02236.x
https://doi.org/10.1046/j.1365-2141.2000.02236.x
Publikováno v:
Thrombosis and Haemostasis. 83:817-821
SummaryThe factor V Leiden mutation (FVL) leads to a seven-fold increased risk of venous thromboembolism (VTE). In thrombophilic families, 25% of carriers have experienced thrombosis before the age of 40 years. Aim of our study was to assess the asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edfc9ed78c41d89bc53b6f9f5af4e2d4
https://doi.org/10.1055/s-0037-1613926
https://doi.org/10.1055/s-0037-1613926
Publikováno v:
Thrombosis and Haemostasis. 77:252-257
SummaryResistance to activated protein C (APC), which is associated with the FV Leiden mutation in the large majority of the cases, is the most common genetic risk factor for thrombosis. Several laboratory tests have been developed to detect the APC-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aaa3cdf8753716038a06c8962b65b1d1
https://doi.org/10.1055/s-0038-1655948
https://doi.org/10.1055/s-0038-1655948
Autor:
F.R. Rosendaal, Pieter H. Reitsma, Ted Koster, C.F. Allaart, Rogier M. Bertina, Jan P. Vandenbroucke, Ruud Lensen, H de Ronde
Publikováno v:
Blood. 88:4205-4208
Both activated protein C (APC) resistance and protein C deficiency are associated with an increased risk for venous thrombosis. To assess their tendencies to venous thrombosis, we compared the median age of first venous thromboembolism in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::040efb2c22c233684bfc66c1496a6ccf
https://doi.org/10.1182/blood.v88.11.4205.4205
https://doi.org/10.1182/blood.v88.11.4205.4205
Autor:
Paul J. Knaepen, Michiel L. Bots, Willem Van Lommel, Ruud Lensen, Filip Casselman, Freddy E.E. Vermeulen
Publikováno v:
The Annals of thoracic surgery. 71(4)
Background . The choice of a valve substitute in young adults requires a decision balancing the risks of long-term anticoagulation versus reoperation(s). This article analyzes the long-term risk and determinants of thromboembolic (TE) and bleeding (B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3a2298c9ab1f2122010dec37cac723a
https://pubmed.ncbi.nlm.nih.gov/11308155
https://pubmed.ncbi.nlm.nih.gov/11308155